CSIMarket
 
Alexion Pharmaceuticals, Inc.  (ALXN)
Other Ticker:  
 
 
Price: $127.5800 $0.60 0.473%
Day's High: $128.83 Week Perf: 3.08 %
Day's Low: $ 126.15 30 Day Perf: 0.34 %
Volume (M): 185 52 Wk High: $ 141.86
Volume (M$): $ 23,485 52 Wk Avg: $124.29
Open: $128.51 52 Wk Low: $93.67



 Market Capitalization (Millions $) 28,769
 Shares Outstanding (Millions) 226
 Employees 2,273
 Revenues (TTM) (Millions $) 4,341
 Net Income (TTM) (Millions $) 416
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 190

Alexion Pharmaceuticals, Inc.
We are a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Our marketed product Soliris® (eculizumab) is the first and only therapeutic approved for patients with two severe and ultra-rare disorders resulting from chronic uncontrolled activation of the complement component of the immune system: paroxysmal nocturnal hemoglobinuria (PNH), a life-threatening and ultra-rare genetic blood disorder, and atypical hemolytic uremic syndrome (aHUS), a life-threatening and ultra-rare genetic disease. We are also evaluating additional potential indications for Soliris in severe and ultra-rare diseases in which chronic uncontrolled complement activation is the underlying mechanism, and we are progressing in various stages of development with additional biotechnology product candidates as treatments for patients with severe and ultra-rare disorders. We were incorporated in 1992 and began commercial sale of Soliris in 2007.


 

Alexion Pharmaceuticals's Segments
 
 
  Company Estimates  
  Revenue Outlook
Alexion Pharmaceuticals announced annual revenue outlook on Oct. 29, 2015

Earnings Outlook
Alexion Pharmaceuticals, Inc. issued annual earnings guidance on Oct. 29, 2015

 
Geographic Revenue Dispersion
United States 35.31 %
Europe 36.89 %
Asia Pacific 14.24 %
Other 13.56 %

Boston Therapeutics, Inc.

Boston Therapeutics, Inc announced first quarter operating deficit of $-0.735919 millions

In the first quarter Boston Therapeutics, Inc lost money of $-0.01 per share compare to $-0.03 a year ago and from $-0.01 per share from the previous quarter.

Sales fell sharply to $0.00 millions from $0.01 millions in the same quarter a year ago and sequentially from $0.01 millions.

Qpagos

Loss on Weak Sales

In the first quarter Qpagos lost money of $-0.01 per share compare to $-0.03 a year ago and from $-0.01 per share from the previous quarter.

Sales declined in double digits by -15.61 % to $1.24 millions from $1.46 millions in the same quarter a year ago and sequentially Sales Tumbled by -56.24 % from $2.83 millions.

Nanovibronix, Inc.

Nanovibronix, Inc announced first quarter operating loss of $-2.223 millions

In the first quarter Nanovibronix, Inc increased losses of $-0.40 per share compare to $-0.12 a year ago and increased losses from $-0.18 per share from the previous quarter.

Sales grew slightly by 2.6 % to $0.08 millions from $0.08 millions in the same quarter a year ago and sequentially Sales surged by 43.64 % from $0.06 millions.

4m Carbon Fiber Corp.

Logged a Loss but Revenues Unchanged

In the first quarter 4m Carbon Fiber Corp lost money of $-0.01 per share compare to $-0.02 a year ago and eps fell from $0.01 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.15 millions.

Verde Resources, Inc.

Sales and Earnings Unchanged

In the third quarter Verde Resources, Inc reached break-even of $-0.00 per share compare to $-0.00 a year ago and from $-0.00 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.01 millions in the same quarter a year ago and sequentially from $0.00 millions.






Customers Net Income grew by ALXN's customers Net margin grew to
33.37 % 4.7 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   
Major Competitors Stock performance

5 Days Decrease / Increase
     
BMY   -3.55%    
CELG   -3.79%    
JNJ        2.61% 
AMGN        2.19% 
• View Complete Report
   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JILL's Profile

Stock Price

JILL's Financials

Business Description

Fundamentals

Charts & Quotes

JILL's News

Suppliers

JILL's Competitors

Customers & Markets

Economic Indicators

JILL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071